Send me a link:

*Text messaging rates may apply.

 Dow Down0.24% Nasdaq Down0.46%

United Therapeutics Corporation (UTHR)

-NasdaqGS
91.21 Down 0.38(0.41%) 11:20AM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 1,116,984   916,076   743,183  
Cost of Revenue131,127  119,297  88,904  
Gross Profit 985,857   796,779   654,279  
Operating Expenses
Research Development299,348  173,387  180,015  
Selling General and Administrative394,010  201,746  156,482  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 292,499   421,646   317,782  
Income from Continuing Operations
Total Other Income/Expenses Net4,462  35,664  2,702  
Earnings Before Interest And Taxes296,961  457,310  320,484  
Interest Expense18,058  16,639  21,367  
Income Before Tax278,903  440,671  299,117  
Income Tax Expense104,343  136,229  81,874  
Minority Interest -   -   -  
Net Income From Continuing Ops174,560  304,442  217,243  
Non-recurring Events
Discontinued Operations -   -  625  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 174,560   304,442   217,868  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 174,560   304,442   217,868  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.